StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Realco S.A.
Brussels Stock Exchange:REAL.BR
Sector
Location
Market Cap
USD 11.25 M
Share Price
USD 17.47
Avg Daily Volume
12
Change (1 day)
0.16%
Change (1 year)
Change (YTD)
22.56%
Realco S.A. Total Assets for the year ending December 31, 2023: USD 19.12 M
Realco S.A. Total Assets is USD 19.12 M for the year ending December 31, 2023, a 2.75% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Realco S.A. Total Assets for the year ending December 31, 2022 was USD 18.61 M, a 22.35% change year over year.
-
Realco S.A. Total Assets for the year ending December 31, 2021 was USD 15.21 M, a 12.19% change year over year.
-
Realco S.A. Total Assets for the year ending December 31, 2020 was USD 13.55 M, a 47.42% change year over year.
-
Realco S.A. Total Assets for the year ending December 31, 2019 was USD 9.19 M, a 4.32% change year over year.
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Lonza Group AG
USD 698.01
LONN.SW
-7.45
-1.06%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
UCB SA
USD 198.91
UCB.BR
+0.11
0.06%
Hansoh Pharmaceutical Group Company Limited
USD 3.95
3692.HK
-0.02
-0.47%
Insmed Incorporated
USD 96.95
INSM
-0.85
-0.87%
Summit Therapeutics Inc.
USD 22.61
SMMT
-1.94
-7.90%
Torrent Pharmaceuticals Limited
USD 38.81
TORNTPHARM.NS
-0.21
-0.53%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Lonza Group AG
USD 698.01
LONN.SW
-7.45
-1.06%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
UCB SA
USD 198.91
UCB.BR
+0.11
0.06%
Hansoh Pharmaceutical Group Company Limited
USD 3.95
3692.HK
-0.02
-0.47%
Insmed Incorporated
USD 96.95
INSM
-0.85
-0.87%
Summit Therapeutics Inc.
USD 22.61
SMMT
-1.94
-7.90%
Torrent Pharmaceuticals Limited
USD 38.81
TORNTPHARM.NS
-0.21
-0.53%